The European Molecular Biology Laboratory (EMBL) is Europe’s only intergovernmental organisation for life science research, services and training. Experimental services are at the heart of all of EMBL’s missions and provide life science researchers in Europe and beyond with access to the very latest in scientific technologies, infrastructure, and data resources. Combined with EMBL’s scientific and technical expertise, these services provide researchers with the highest quality results, and enable significant fundamental research that is essential to solving global societal challenges.

EMBL has commissioned Technopolis to carry out an Impact Assessment of EMBL’s experimental services to understand the value these services have for its external user community.

It is a voluntary survey. None of the questions are mandatory and you can withdraw at any time. All individual answers will be treated in strict confidence and will be used by Technopolis for the sole purpose of the EMBL Impact Assessment. The findings will be published in aggregate form only, individual responses will not be attributable to you or your organisation.

Thank you for taking the time to complete the survey – your participation is extremely important to inform the assessment and help EMBL understand the value these services have for its external user community. The survey will remain open until 30 June 2021 and should take about 20 minutes to complete.

If you have any further questions about the online survey or review, please contact the Technopolis Project Manager Dr Rebecca Babb (rebecca.babb@technopolis-group.com).

Technopolis is a registered data manager under the UK Data Protection Act and complies with EU GDPR regulation. We have established processes to ensure the security of the data and information that we collect and hold. For more information about Technopolis’ privacy policy, please visit https://www.technopolis-group.com/privacy-policy/.

T